======= ANGPT4 ======= == Gene Information == * **Official Symbol**: ANGPT4 * **Official Name**: angiopoietin 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51378|51378]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y264|Q9Y264]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANGPT4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANGPT4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603705|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds to TEK/TIE2, modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of TEK/TIE2. Promotes endothelial cell survival, migration and angiogenesis. {ECO:0000269|PubMed:15284220}. |Fibrinogen C| |transmembrane receptor protein tyrosine kinase activator activity| |activation of transmembrane receptor protein tyrosine kinase activity| |endothelial cell proliferation| |negative regulation of blood vessel endothelial cell migration| |negative regulation of endothelial cell migration| |positive regulation of blood vessel endothelial cell migration| |receptor tyrosine kinase binding| |negative regulation of epithelial cell migration| |epithelial cell proliferation| |regulation of blood vessel endothelial cell migration| |positive regulation of endothelial cell migration| |negative regulation of angiogenesis| |negative regulation of blood vessel morphogenesis| |negative regulation of vasculature development| |Notch signaling pathway| |positive regulation of epithelial cell migration| |regulation of endothelial cell migration| |positive regulation of angiogenesis| |positive regulation of vasculature development| |cellular response to hypoxia| |positive regulation of peptidyl-tyrosine phosphorylation| |cellular response to decreased oxygen levels| |cellular response to oxygen levels| |regulation of epithelial cell migration| |regulation of peptidyl-tyrosine phosphorylation| |negative regulation of cell migration| |negative regulation of cell motility| |regulation of angiogenesis| |negative regulation of cellular component movement| |angiogenesis| |regulation of vasculature development| |negative regulation of locomotion| |activation of protein kinase activity| |response to hypoxia| |response to decreased oxygen levels| |leukocyte migration| |response to oxygen levels| |blood vessel morphogenesis| |blood vessel development| |positive regulation of cell migration| |transmembrane receptor protein tyrosine kinase signaling pathway| |vasculature development| |cardiovascular system development| |positive regulation of cell motility| |positive regulation of protein kinase activity| |positive regulation of cellular component movement| |positive regulation of locomotion| |cell population proliferation| |positive regulation of kinase activity| |tube morphogenesis| |positive regulation of transferase activity| |enzyme linked receptor protein signaling pathway| |regulation of protein kinase activity| |cellular protein-containing complex assembly| |tube development| |regulation of cell migration| |circulatory system development| |regulation of kinase activity| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |regulation of cell motility| |negative regulation of developmental process| |cell migration| |regulation of transferase activity| |regulation of locomotion| |regulation of cellular component movement| |negative regulation of cell death| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |response to abiotic stimulus| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |locomotion| |positive regulation of developmental process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of apoptotic process| |movement of cell or subcellular component| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |regulation of cell death| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |protein-containing complex subunit organization| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13396 * **Expression level (log2 read counts)**: 1.53 {{:chemogenomics:nalm6 dist.png?nolink |}}